Hence, dysadherin overexpression may promote the growth of breast cancer by increasing CCL2 expression [45]. By enhancing the expression of CCL2, mesenchymal stem cells promote cell proliferation in heterogeneous TNBC [46]. The gene discussed is FXYD5; the disease is breast cancer.